Ramsay Stattman Vela & Price Inc. grew its holdings in Danaher Co. (NYSE:DHR) by 1.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 85,156 shares of the conglomerate’s stock after purchasing an additional 1,060 shares during the quarter. Danaher makes up approximately 3.4% of Ramsay Stattman Vela & Price Inc.’s portfolio, making the stock its 7th largest holding. Ramsay Stattman Vela & Price Inc.’s holdings in Danaher were worth $9,253,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in DHR. Mount Yale Investment Advisors LLC purchased a new position in shares of Danaher during the first quarter valued at approximately $103,000. IMS Capital Management purchased a new position in shares of Danaher during the second quarter valued at approximately $107,000. BerganKDV Wealth Management LLC purchased a new position in shares of Danaher during the second quarter valued at approximately $111,000. Fort L.P. purchased a new position in shares of Danaher during the second quarter valued at approximately $119,000. Finally, Braun Bostich & Associates Inc. lifted its stake in shares of Danaher by 506.4% during the second quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after buying an additional 1,023 shares during the period. Institutional investors and hedge funds own 76.80% of the company’s stock.
In other Danaher news, EVP William K. Daniel sold 29,784 shares of the stock in a transaction that occurred on Thursday, October 25th. The shares were sold at an average price of $98.04, for a total transaction of $2,920,023.36. Following the transaction, the executive vice president now owns 141,892 shares of the company’s stock, valued at $13,911,091.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP William K. Daniel sold 103,086 shares of the stock in a transaction that occurred on Friday, August 10th. The stock was sold at an average price of $100.63, for a total transaction of $10,373,544.18. Following the transaction, the executive vice president now directly owns 167,080 shares in the company, valued at approximately $16,813,260.40. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 143,448 shares of company stock worth $14,306,623. 11.90% of the stock is currently owned by insiders.
Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.07 by $0.03. The company had revenue of $4.85 billion for the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a net margin of 14.07% and a return on equity of 11.59%. Danaher’s revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the firm posted $1.00 earnings per share. On average, equities analysts predict that Danaher Co. will post 4.51 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, October 26th. Shareholders of record on Friday, September 28th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date was Thursday, September 27th. Danaher’s dividend payout ratio is currently 15.88%.
DHR has been the topic of several recent analyst reports. ValuEngine raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Thursday, July 12th. Morgan Stanley upped their price objective on shares of Danaher from $113.00 to $120.00 and gave the company an “overweight” rating in a research note on Friday, July 13th. Zacks Investment Research downgraded shares of Danaher from a “hold” rating to a “sell” rating in a research note on Monday, July 16th. Bank of America set a $113.00 price objective on shares of Danaher and gave the company a “buy” rating in a research note on Thursday, July 19th. Finally, Royal Bank of Canada upped their price objective on shares of Danaher to $107.00 and gave the company a “positive” rating in a research note on Thursday, July 19th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company. Danaher has a consensus rating of “Buy” and a consensus price target of $112.14.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Featured Article: How to Invest in the Dividend Aristocrat Index
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.